Back to Search
PETER LE, MD
MD
Internal Medicine Physician
NPI: 1265655773IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A85765(CA)
Pulmonary Disease Physician
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
A85765(CA)
Education
UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Escherichia coli expression and refolding of E/K-coil-tagged EGF generates fully bioactive EGF for diverse applications.
PMID 19061959·Protein Expr Purif·2009
8-other
Biosynthetic production of universally (13)C-labelled polyunsaturated fatty acids as reference materials for natural health product research.
PMID 17486321·Anal Bioanal Chem·2007
8-other
The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat.
PMID 15325727·J Ethnopharmacol·2004
4-observational
Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum.
PMID 12584249·J Cell Sci·2003
7-preclinical
Bond failure and decalcification: A comparison of a cyanoacrylate and a composite resin bonding system in vivo.
PMID 12806340·Am J Orthod Dentofacial Orthop·2003
4-observational
Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum.
PMID 11724808·J Biol Chem·2002
7-preclinical
Human thymic epithelial cells inhibit IL-15- and IL-2-driven differentiation of NK cells from the early human thymic progenitors.
PMID 11160272·J Immunol·2001
8-other
Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility.
PMID 10954421·J Cell Sci·2000
7-preclinical
Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.
PMID 19456838·Clin Microbiol Infect·2010
8-other
Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors.
PMID 19648014·Bioorg Med Chem·2009
7-preclinical
Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production.
PMID 19221591·PLoS One·2009
7-preclinical
The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans.
PMID 17990118·J Immigr Minor Health·2009
8-other
Synthesis of four novel natural product inspired scaffolds for drug discovery.
PMID 19105637·J Org Chem·2009
8-other
Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.
PMID 18941456·Br J Cancer·2008
8-other
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
PMID 18701262·Int J Antimicrob Agents·2008
8-other
DNA sequences in gal operon override transcription elongation blocks.
PMID 18691599·J Mol Biol·2008
8-other
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
PMID 18800760·J Med Chem·2008
7-preclinical
Frequency of cyclic lumbar loading is a risk factor for cumulative trauma disorder.
PMID 18508342·Muscle Nerve·2008
7-preclinical
In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin A.
PMID 18426902·Antimicrob Agents Chemother·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 275 W MACARTHUR
OAKLAND, CA 94611 - Phone
- (510) 752-1000
Quick Facts
- NPI
- 1265655773
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile